Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis
- PMID: 17144780
- DOI: 10.1586/14737175.6.11.1657
Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis
Abstract
Glucocorticoids exert a variety of immunomodulatory activities. Since changes in glucocorticoid homeostasis impact on susceptibility to autoimmune diseases, and synthetic glucocorticoids are widely used in the treatment of multiple sclerosis, a detailed understanding of their mechanism of action is desirable. Experimental autoimmune encephalomyelitis is a common animal model that mirrors many hallmarks of multiple sclerosis, a chronic inflammatory disease of the CNS with presumed autoimmune origin. Experimental autoimmune encephalomyelitis has been instrumental for many years in studying multiple sclerosis, revealing the blood-brain barrier, the microglia and T-cell apoptosis as major targets of glucocorticoids in this disease. Despite the great advances in the field, the answers to many questions concerning the mechanism of glucocorticoids; for example, the contribution of nongenomic effects or the cell-type specificity of their action, remain elusive. This review will critically discuss what we have learned so far from the analysis of animal models of the molecular mode of therapeutic and endogenous glucocorticoid action in multiple sclerosis. With this knowledge in mind, we should be able to further improve the management of multiple sclerosis using this class of drugs.
Similar articles
-
Glucocorticoids in the control of neuroinflammation.Mol Cell Endocrinol. 2007 Sep 15;275(1-2):62-70. doi: 10.1016/j.mce.2007.03.007. Epub 2007 May 4. Mol Cell Endocrinol. 2007. PMID: 17555867 Review.
-
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.Brain. 2003 Aug;126(Pt 8):1895-904. doi: 10.1093/brain/awg176. Epub 2003 Jun 4. Brain. 2003. PMID: 12805101
-
Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.Brain Res Brain Res Rev. 2004 Nov;46(3):261-81. doi: 10.1016/j.brainresrev.2004.06.006. Brain Res Brain Res Rev. 2004. PMID: 15571769 Review.
-
The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.Immunopharmacol Immunotoxicol. 2009;31(1):32-8. doi: 10.1080/08923970802379819. Immunopharmacol Immunotoxicol. 2009. PMID: 18792835 Review.
-
The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.Inflammopharmacology. 2007 Oct;15(5):183-7. doi: 10.1007/s10787-007-1607-z. Inflammopharmacology. 2007. PMID: 17943249 Review.
Cited by
-
Combined Treatment with Methylprednisolone and Human Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis.Tissue Eng Regen Med. 2018 Jan 25;15(2):183-194. doi: 10.1007/s13770-017-0101-y. eCollection 2018 Apr. Tissue Eng Regen Med. 2018. PMID: 30603546 Free PMC article.
-
Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.Mol Endocrinol. 2010 Feb;24(2):310-22. doi: 10.1210/me.2009-0236. Epub 2009 Dec 4. Mol Endocrinol. 2010. PMID: 19965930 Free PMC article.
-
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling.Cells. 2023 Sep 15;12(18):2291. doi: 10.3390/cells12182291. Cells. 2023. PMID: 37759513 Free PMC article.
-
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis.J Neuroinflammation. 2009 Dec 11;6:37. doi: 10.1186/1742-2094-6-37. J Neuroinflammation. 2009. PMID: 20003332 Free PMC article.
-
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.Int J Clin Exp Med. 2015 Nov 15;8(11):20188-97. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26884931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical